目前,美国有八万病人靠长期透析维持生命,而这个数字只是急慢性肾功能损伤人群的一小部分。急慢性肾衰患者的出血倾向增高已被公认,这种并发症的临床重要性在于它仍然是导致尿毒症发病及死亡的主要因素。出血最常见的临床表现为粘膜出血,特别是胃肠道出血,其它还有瘀斑、彝衄、出血性心包炎和硬脑膜下血肿。消化道出血约为急性肾衰病人的30％—40％,据一较大范围的调查,其死亡人数为整个死亡人数的30％。慢性肾衰的出血并发症比急性肾衰更多。未经透析的病人为60％,透析的病人达70％。鉴于急慢性肾衰并发出血惊人之多,本文将对尿毒症出血治疗方法进行简单的评论。虽然已经描述了几种基本凝血失常,但对主要凝血缺限仍未阐明,这包括血小板因子Ⅲ增殖不全、血 At present, there are 80,000 patients in the United States who rely on long-term dialysis to maintain their lives, and this figure is only a small part of the acute and chronic renal impairment group. The increased bleeding tendencies in patients with acute and chronic renal failure have been well recognized, and the clinical importance of this complication is that it is still the major cause of the onset and death of uremia. Bleeding the most common clinical manifestations of mucosal bleeding, especially gastrointestinal bleeding, there are other petechiae, Yi Yi, hemorrhagic pericarditis and subdural hematoma. Gastrointestinal bleeding is about 30% -40% of patients with acute renal failure, according to a larger survey, the death toll was 30% of the entire death toll. Chronic renal failure bleeding complications than acute renal failure more. 60% of patients without dialysis, dialysis patients up to 70%. In view of the alarming number of acute and chronic renal failure complicated by bleeding, this article will be a simple comment on the treatment of uremic bleeding. Although several basic coagulation disorders have been described, the major coagulation limitations have not been elucidated, and this includes platelet factor III hyperplasia, blood